Owlet Inc
NYSE:OWLT
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
3.35
6.9
|
| Price Target |
|
We'll email you a reminder when the closing price reaches USD.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
Owlet Inc
Owlet Inc
Cash Equivalents
Owlet Inc
Cash Equivalents Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Cash Equivalents | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Owlet Inc
NYSE:OWLT
|
Cash Equivalents
$16.6m
|
CAGR 3-Years
-1%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Becton Dickinson and Co
NYSE:BDX
|
Cash Equivalents
$1.7B
|
CAGR 3-Years
-9%
|
CAGR 5-Years
26%
|
CAGR 10-Years
-1%
|
|
|
Boston Scientific Corp
NYSE:BSX
|
Cash Equivalents
$2.5B
|
CAGR 3-Years
9%
|
CAGR 5-Years
55%
|
CAGR 10-Years
26%
|
|
|
Stryker Corp
NYSE:SYK
|
Cash Equivalents
$3.9B
|
CAGR 3-Years
15%
|
CAGR 5-Years
15%
|
CAGR 10-Years
11%
|
|
|
Abbott Laboratories
NYSE:ABT
|
Cash Equivalents
$7B
|
CAGR 3-Years
-9%
|
CAGR 5-Years
11%
|
CAGR 10-Years
7%
|
|
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
Cash Equivalents
$1.8B
|
CAGR 3-Years
32%
|
CAGR 5-Years
23%
|
CAGR 10-Years
14%
|
|
Owlet Inc
Glance View
Owlet, Inc. is a digital parenting platform, which provides parents real-time data and insights of parenting. The company is headquartered in Los Angeles, California. The company went IPO on 2020-09-15. The firm's platform focuses on giving real-time data and insights to parents. Its products include owlet dream sock, an app to assist children with better sleep; owlet cam, a video streaming app to hear and see the baby from anywhere, and dream lab, an online and interactive sleep training program for babies. The firm offers sock monitor offerings, which include Smart Sock and Dream Sock and Dream Sock Plus; Cam; Monitor Duo/Dream Duo; Dream Lab, and accessories. Its monitoring pipeline includes Sock Versions, which includes Smart Sock Plus, Over-the-Counter (OTC) Smart Sock and BabySat, and Band. The Company’s products are available for purchase at global and national retail stores, as well as through online channels on Amazon.com and other online retail sites, as well as its direct-to-consumer channel on its country-specific Websites.
See Also
What is Owlet Inc's Cash Equivalents?
Cash Equivalents
16.6m
USD
Based on the financial report for Dec 31, 2023, Owlet Inc's Cash Equivalents amounts to 16.6m USD.
What is Owlet Inc's Cash Equivalents growth rate?
Cash Equivalents CAGR 3Y
-1%
Over the last year, the Cash Equivalents growth was 48%. The average annual Cash Equivalents growth rates for Owlet Inc have been -1% over the past three years .
You don't have any saved screeners yet
